TTAM (TTAM) Stock Price & Analysis
TTAM (TTAM) rose 2.80% to USD 15.8 as of June 10, 2026 at 03:07 UTC, according to Nexqual real-time market data.
TTAM last closed at USD 15.37; the session ranged USD 15.16–15.95 on volume of 636,461 shares. Market capitalization is $2.91B, with a 52-week range of USD 12.18–19.42 (NYQ). Source: Nexqual, June 10, 2026 at 03:07 UTC.
Key Statistics (as of June 10, 2026 at 03:07 UTC)
| Price | USD 15.8 |
|---|---|
| Change | ▲ 2.80% (up) |
| Previous Close | USD 15.37 |
| Open | USD 15.54 |
| Day Range | USD 15.16 – 15.95 |
| 52-Week Range | USD 12.18 – 19.42 |
| Volume | 636,461 shares |
| Market Cap | $2.91B |
| Exchange | NYQ |
Technical Analysis (TTAM)
Nexqual's technical model rates TTAM "SELL" based on 1 bullish and 4 bearish signals across 124 daily candles, as of June 10, 2026 at 03:07 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 48.03 (neutral) |
| vs SMA50 | Below (USD 15.97) |
| MACD | -0.1 (negative) |
Analyst Ratings (TTAM)
Wall Street analysts rate TTAM "None" based on 7 analysts, with a mean price target of USD 17.79 (range USD 15–20), per Nexqual as of June 10, 2026 at 03:07 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 7 |
| Mean Target | USD 17.79 |
| High Target | USD 20 |
| Low Target | USD 15 |
| Buy / Hold / Sell | 2 / 4 / 1 |
Earnings (TTAM)
| Next Earnings Date | 2026-07-29 |
|---|---|
| EPS Estimate | USD 0.27 |
| Revenue Estimate | $444.49M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.2 vs est 0.2 ▼ miss |
| 2025-12-31 | USD 0.26 vs est 0.24 ▲ beat |
| 2025-09-30 | USD 0.33 vs est 0.31 ▲ beat |
| 2025-06-30 | USD 0.27 vs est 0.31 ▼ miss |
Source: Nexqual, June 10, 2026 at 03:07 UTC.
Financials & Fundamentals (TTAM)
| Total Revenue | $1.67B |
|---|---|
| Revenue Growth (YoY) | +1.50% |
| Gross Margin | +27.16% |
| Operating Margin | +12.50% |
| Profit Margin | +11.08% |
| ROE | +18.72% |
| Debt / Equity | 42.89 |
| Current Ratio | 2.99 |
| Total Cash | $228.25M |
| Total Debt | $455.24M |
| Free Cash Flow | $111.26M |
Source: Nexqual, June 10, 2026 at 03:07 UTC.
Financial Health Score (TTAM)
Nexqual rates TTAM's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 03:07 UTC.
| Growth | Mixed — Revenue +1.8% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 27%, operating 12% |
| Balance Sheet | Strong — $228M cash vs $455M debt |
| Cash Flow | Solid — FCF $111M, 7% margin |
| Efficiency | Solid — ROE 19%, ROA 9.1% |
Ownership (TTAM)
| Insider Ownership | +86.68% |
|---|---|
| Institutional Ownership | +16.28% |
| Shares Outstanding | 184.36M |
| Float | 24.55M |
| Short % of Float | +11.95% |
Source: Nexqual, June 10, 2026 at 03:07 UTC.
Leadership (TTAM)
TTAM is led by Vassilios S. Zarkalis (age 64), President, CEO & Director, per Nexqual as of June 10, 2026 at 03:07 UTC.
| President, CEO & Director | Vassilios S. Zarkalis (age 64) |
|---|---|
| Chief Financial Officer | Lawrence H. Wilt (age 60) |
| President of Titan Mid-Atlantic | Kevin Baird (age 57) |
| President of Florida Business Unit | Jason Morin (age 53) |
| Executive Director of Growth & Strategy | Randy Dunlap (age 70) |
Major Backers & Investors (TTAM)
Notable institutional backers of TTAM include American Century Companies Inc, Victory Capital Management Inc., River Road Asset Management, LLC, according to Nexqual as of June 10, 2026 at 03:07 UTC.
Active Investors
| Investor | Stake |
|---|---|
| American Century Companies Inc | 3.76% |
| Victory Capital Management Inc. | 2% |
| River Road Asset Management, LLC | 1.7% |
| Voss Capital, LP | 1.6% |
| Victory Portfolios-Victory Sycamore Small Company Opportunity Fund | 1.42% |
| Allspring Global Investments Holdings, LLC | 1.25% |
| Mirae Asset Global ETFs Holdings Ltd. | 1.19% |
| GLOBAL X FUNDS-Global X US Infrastructure Development ETF | 1.16% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 0.97% |
Source: Nexqual, June 10, 2026 at 03:07 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AMRZ | Amrize Ltd | USD 52.69 | ▼ 1.66% |
| FLOC | Flowco Holdings Inc. | USD 23.66 | ▲ 2.07% |
| KNF | Knife Riv Holding Co. | USD 76.29 | ▲ 2.87% |
| SLDE | Slide Insurance Holdings, Inc. | USD 16.71 | ▼ 0.18% |
| KMTS | Kestra Medical Technologies, Lt | USD 19.92 | ▲ 2.68% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:07 UTC. This page is informational and not investment advice.